论文部分内容阅读
Objective:The aim of the study was to evaluate the efficacy and toxicity of high power focused-beam microwave hyperthermia with intrapleural injection of Shapeilin for patients with malignant hydrothorax.Methods:Fifty-eight patients with malignant hydrothorax were divided into group A and group B randomly.All patients underwent indwelling pleural catheter and were treated by intrapleural injection of Shapeilin once three days.Treatment was composed of 3 times injection.Patients of group B received high power focused-beam microwave hyperthermia after injection of Shapeilin.Results:The response rate of group B(79.3%) was higher than that of group A(48.3%)(P < 0.05).Incidence of main adverse reactions,associated with Shapeilin,of two groups including fever and thoracodynia were similar(P > 0.05).Patients of group B didn’t encounter severe toxicities of microwave hyperthermia.Conclusion:High power focused-beam microwave hyperthermia combined with intrapleural injection of Shapeilin is effective and tolerable for patients with malignant hydrothorax.
Objective: The aim of the study was to evaluate the efficacy and toxicity of high power focused-beam microwave hyperthermia with intrapleural injection of Shapeilin for patients with malignant hydrothorax. Methods: Fifty-eight patients with malignant hydrothorax were divided into groups A and B randomly selected. Patients underwent indwelling pleural catheter and were treated by intrapleural injection of Shapeilin once three days. Treatment was composed of 3 times injection. Patients of group B received high power focused-beam microwave hyperthermia after injection of Shapeilin. Results: The response rate Of group B (79.3%) was higher than that of group A (48.3%) (P <0.05) .Incidence of main adverse reactions, associated with Shapeilin, of two groups including fever and thoracodynia were similar of group B did not encounter severe toxicities of microwave hyperthermia. Conlusion: High power focused-beam microwave hyperthermia combined with intrapleural injection of Shapeilin is effector ctive and tolerable for patients with malignant hydrothorax.